1) Severe Urological sepsis
泌尿系重症脓毒症
2) urosepsis
尿脓毒症
3) Severe sepsis
重症脓毒症
1.
Recombinant Human Activated Protein C(rhAPC),a drug treating for severe sepsis,had been suggested that its marketing strategy may has affected the professional organization on developing and implementing related guidelines.
重组人类活性蛋白C(rhAPC)为治疗重症脓毒症的药物,目前有证据表明rhAPC的市场策略有可能已经影响到专业机构诊治指南的制定与执行;rhAPC的临床疗效亦未能被大型临床试验继续证实,因此目前rhAPC的临床应用以及疗效评价要慎重进行。
2.
The current incidence of sepsis is at least 240 patients per 100,000 people in the United States population,whereas for severe sepsis it is between 51 and 95 patients per 100,000 people.
研究背景 脓毒症(sepsis)是病原微生物入侵机体后引起的全身炎症反应综合征(SIRS),其后续症包括重症脓毒症(severe sepsis)、脓毒症休克(septic shock)、多器官功能不全(MODS)。
4) severe sepsis
重度脓毒症
1.
Impact of molecular adsorbent recirculating system on heart rate and arterial pressure in patients of coronary heart disease complicated with severe sepsis;
分子吸附再循环系统对冠心病并发重度脓毒症患者心率和动脉压的影响
2.
Objective To study the anti-inflammatory effect and the therapeutic efficacy of Qishen Huoxue Granule(QHG)in treating severe sepsis.
目的探讨中药芪参活血颗粒在重度脓毒症治疗中的抗炎作用及临床疗效。
3.
Objective To investigate the significance of changes in plasma levels of acute phase proteins (APPs) in patients with sepsis and severe sepsis by serial analysis.
目的 研究血清急性时相蛋白水平在脓毒症和重度脓毒症患者炎症过程中的变化及其临床意义。
5) Severe sepsis
严重脓毒症
1.
Clinical significance of early lactate clearance in patients with severe sepsis after surgery;
早期乳酸清除率评估外科严重脓毒症预后的临床价值研究
2.
Clinical study and long-term evaluation of immunomodulation therapy on trauma,severe sepsis and multiple organ dysfunction syndrome patients;
创伤性严重脓毒症和多器官功能障碍综合征免疫调理治疗的临床研究和远期评价
3.
Clinical significance of detection of thrombus precursor protein in severe sepsis;
血栓前体蛋白测定在严重脓毒症中的临床意义
补充资料：肾性葡萄糖尿氨基酸尿磷酸盐尿症
肾性葡萄糖尿氨基酸尿磷酸盐尿症
renal glucosuria aminoaciduria and phosphaturia
又称“Fanconi综合征”。遗传性或获得性近端肾小管多种功能异常疾病。临床上表现为肾性糖尿、全氨基酸尿、磷酸盐尿、高血氯性代谢性酸中毒、低血钾、多尿及肾小管性蛋白尿等。遗传性Fanconi综合征又可分为成人型及婴儿型两类，后者又称为“de-Toni-Debre-Fanconi综合征”或“Lignac-Fonconi综合征”。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条